Metropolis, Dr Lal PathLabs shares dip up to 3% as Amazon enters diagnostic market

Diagnostic stocks like Metropolis Healthcare and Dr Lal PathLabs fell up to 3% on June 23 as Amazon launched home diagnostic services, increasing competition in India's diagnostics market valued at $15 billion.

Markets